Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-01-19
1998-12-08
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144
Patent
active
058469842
ABSTRACT:
6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridinone, also known as ciclopirox, and its salts such as ciclopirox olamine are used to inhibit neuronal cell damage or neuronal cell death.
REFERENCES:
patent: 3644626 (1972-02-01), Witzel
patent: 3655897 (1972-04-01), Witzel
patent: 3883545 (1975-05-01), Lohaus et al.
patent: 4185106 (1980-01-01), Dittmar et al.
patent: 4711775 (1987-12-01), Dittmar et al.
patent: 5231112 (1993-07-01), Janoff et al.
Abstracts, 19: 885 (1993).
Ferrari, G. and Greene, L.A. (1994). Proliferative inhibition by dominant-negative Ras rescues naive and neuronally differentiated PC12 cells from apoptotic death. The EMBO Journal, 13: 5922-5928 and;.
Brooks, S.F. et al., (1993). Apoptosis induced by NGF-withdrawal from differentiated PC12 cells involved activation of p34.sup.cdc2 kinase. Society For Neuroscience Abstracs, 19: 885.
Farinelli, S.E. et al., (1993). A possible link between the cell cycle and apoptosis of PC12 cells. Society For Neuroscience.
Urbani, L. et al., (1995). Dissociation of nuclear and cytoplasmic cell cycle progression by drugs employed in cell synchronization. Experimental Cell Research, 219: 159-168.
Farinelli Stephen E.
Greene Lloyd A.
Criares Theodore J.
The Trustees of Columbia University in the City of New York
White John P.
LandOfFree
Use of ciclopirox or a pharmaceutically acceptable salt thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of ciclopirox or a pharmaceutically acceptable salt thereof , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of ciclopirox or a pharmaceutically acceptable salt thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-177548